Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2278474rdf:typepubmed:Citationlld:pubmed
pubmed-article:2278474lifeskim:mentionsumls-concept:C0153381lld:lifeskim
pubmed-article:2278474lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:2278474lifeskim:mentionsumls-concept:C0348026lld:lifeskim
pubmed-article:2278474lifeskim:mentionsumls-concept:C0163275lld:lifeskim
pubmed-article:2278474lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:2278474lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:2278474lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:2278474pubmed:issue2lld:pubmed
pubmed-article:2278474pubmed:dateCreated1991-3-1lld:pubmed
pubmed-article:2278474pubmed:abstractTextSerum Fibrin Degradation Products (FDP) were determined in 50 oral cancer patients and 50 normal individuals prior to any kind of treatment. The mean FDP values were significantly increased with the advancement of stage of oral cancer patients in comparison to the normal individuals.lld:pubmed
pubmed-article:2278474pubmed:languageenglld:pubmed
pubmed-article:2278474pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2278474pubmed:citationSubsetDlld:pubmed
pubmed-article:2278474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2278474pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2278474pubmed:statusMEDLINElld:pubmed
pubmed-article:2278474pubmed:issn0003-4770lld:pubmed
pubmed-article:2278474pubmed:authorpubmed-author:GhoseNNlld:pubmed
pubmed-article:2278474pubmed:authorpubmed-author:AroorA RARlld:pubmed
pubmed-article:2278474pubmed:authorpubmed-author:RaghavanM RMRlld:pubmed
pubmed-article:2278474pubmed:issnTypePrintlld:pubmed
pubmed-article:2278474pubmed:volume49lld:pubmed
pubmed-article:2278474pubmed:ownerNLMlld:pubmed
pubmed-article:2278474pubmed:authorsCompleteYlld:pubmed
pubmed-article:2278474pubmed:pagination11-2, 45lld:pubmed
pubmed-article:2278474pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2278474pubmed:meshHeadingpubmed-meshheading:2278474-...lld:pubmed
pubmed-article:2278474pubmed:meshHeadingpubmed-meshheading:2278474-...lld:pubmed
pubmed-article:2278474pubmed:meshHeadingpubmed-meshheading:2278474-...lld:pubmed
pubmed-article:2278474pubmed:meshHeadingpubmed-meshheading:2278474-...lld:pubmed
pubmed-article:2278474pubmed:meshHeadingpubmed-meshheading:2278474-...lld:pubmed
pubmed-article:2278474pubmed:meshHeadingpubmed-meshheading:2278474-...lld:pubmed
pubmed-article:2278474pubmed:meshHeadingpubmed-meshheading:2278474-...lld:pubmed
pubmed-article:2278474pubmed:meshHeadingpubmed-meshheading:2278474-...lld:pubmed
pubmed-article:2278474pubmed:meshHeadingpubmed-meshheading:2278474-...lld:pubmed
pubmed-article:2278474pubmed:meshHeadingpubmed-meshheading:2278474-...lld:pubmed
pubmed-article:2278474pubmed:year1990lld:pubmed
pubmed-article:2278474pubmed:articleTitleClinical utility of serum fibrinogen degradation products (FDP) in the diagnostic and prognostic evaluation of oral cancer.lld:pubmed
pubmed-article:2278474pubmed:affiliationDepartment of Oral Medicine, College of Dental Surgery, Kasturba Medical College, Manipal, India.lld:pubmed
pubmed-article:2278474pubmed:publicationTypeJournal Articlelld:pubmed